Blockade of αvβ3 and αvβ5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells
Open Access
- 1 November 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (9), 3035-3044
- https://doi.org/10.1182/blood-2006-05-023580
Abstract
Proteolytic events at the cell surface are essential in the regulation of signal transduction pathways. During the past years, the family of type II transmembrane serine proteases (TTSPs) has acquired an increasing relevance because of their privileged localization at the cell surface, although our current understanding of the biologic function of most TTSPs is limited. Here we show that matriptase-2 (Tmprss6), a recently described member of the TTSP family, is an essential regulator of iron homeostasis. Thus, Tmprss6−/− mice display an overt phenotype of alopecia and a severe iron deficiency anemia. These hematologic alterations found in Tmprss6−/− mice are accompanied by a marked up-regulation of hepcidin, a negative regulator of iron export into plasma. Likewise, Tmprss6−/− mice have reduced ferroportin expression in the basolateral membrane of enterocytes and accumulate iron in these cells. Iron-dextran therapy rescues both alopecia and hematologic alterations of Tmprss6−/− mice, providing causal evidence that the anemic phenotype of these mutant mice results from the blockade of intestinal iron export into plasma after dietary absorption. On the basis of these findings, we conclude that matriptase-2 activity represents a novel and relevant step in hepcidin regulation and iron homeostasis.Keywords
This publication has 50 references indexed in Scilit:
- Endogenous Inhibitors of AngiogenesisCancer Research, 2005
- Integrins and AngiogenesisPublished by Elsevier ,2004
- IntegrinsCell, 2002
- Complexity and specificity of integrin signallingNature Cell Biology, 2000
- Role of Integrin αvβ3 in Vascular BiologyThrombosis and Haemostasis, 1998
- Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.Proceedings of the National Academy of Sciences, 1996
- Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularizationNature Medicine, 1996
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.Journal of Clinical Investigation, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994